News

14/12/2022

Two biomarkers identified in patients with amyotrophic lateral sclerosis (ALS)

A study carried out by researchers from the Neuromuscular Diseases laboratory of the Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant-Pau and the Memory Unit of the Neurology ...

13/12/2022

Molecular hydrogen as a new strategy for the treatment of chronic pain

Twenty per cent of the Spanish population suffers from chronic pain, and between 7 and 10% from neuropathic pain. This condition, mostly caused by nerve damage, causes people to feel intense and const...

12/12/2022

Two innovative projects from Sant Pau, presented in The Collider’s OnCampus programme

The Innovation team of the Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau has presented two innovative projects created entirely by professionals from Sant Pau at The Co...

05/12/2022

A study on a rare disease helps to identify the mechanism that explains the appearance of head and neck tumors in the general population

An international study in which researchers from the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau and the Universitat Autònoma de Barcelona (UAB) have participated ...

30/11/2022

Exheus, spin-off of Sant Pau, completes a capital increase and prepares for international market entry

Exheus, a genetics and data science company specializing in RNA analysis, spin-off of the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, the Universitat Politècnica ...